An Alternative Dosing Schedule of Varenicline for Smoking Cessation



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:March 2009
End Date:July 2015

Use our guide to learn which trials are right for you!

Extended Varenicline for Smoking Cessation: A Pilot Study

The purpose of this study is to explore the use of an prolonged alternative dosing schedule
using varenicline for smoking cessation leading to greater quit rates and higher rates of
continuous abstinence.

This pilot study will utilize a two group randomized design. Adult smokers who are motivated
to quit smoking will be randomized to one of two treatment groups. Both groups will receive
brief support counseling. During a one-week baseline and the 4-week pre-quit period smoking
rate, smoking satisfaction, withdrawal, and craving will be assessed on a daily basis.

Inclusion Criteria:

- currently smoking at least 15 cigarettes daily

- in good health

- able to read and speak English fluently

- have a home telephone and plan to reside in Western New York for 6 months

- willing to make quit attempt

- signed informed consent

- who planned quit attempt.

Exclusion Criteria:

- serious medical condition

- depression or mental health condition requiring treatment in the past year

- history of panic disorder, psychosis, bipolar disorder

- alcohol or drug abuse in the past year

- use of tobacco products other than cigarettes

- current use of other cessation pharmacotherapies

- pregnancy/planned pregnancy.
We found this trial at
1
site
666 Elm Street
Buffalo, New York 14263
(716) 845-2300
Roswell Park Cancer Institute Welcome to Roswell Park Cancer Institute (RPCI), America's first cancer center...
?
mi
from
Buffalo, NY
Click here to add this to my saved trials